# Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer

> **NCT03828838** · PHASE1,PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Prostate Neoplasm

## Interventions

- **DRUG:** Lu-177 PSMA-617

## Key facts

- **NCT ID:** NCT03828838
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03828838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03828838, "Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03828838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*